Data from the first half of 2025 indicate an increase in seed and Series A financing rounds within biotech, with $4.7 billion raised. However, the funding landscape is marked by concentration, with a small number of companies capturing a significant share of capital. This trend reflects evolving investor strategies and market conditions, influencing the early-stage biotech ecosystem and highlighting the competitive environment for securing venture capital.